RJ, correct me if I am wrong, but from my understanding Moderna is in the lead as they are the first to start clinical trials, however, they start from scratch with Phase I, but according to my understanding of the matter, GNBT management things that they can basically jump at least the phase I, because they have done phase I and II with similar vaccines for bird flu, swine flu etc. So if that assumption would hold true, they can very quickly regain the lead.
Just my two cents.